Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High risk human papillomavirus genotyping in clinical samples: evaluation of different commercial tests.

International journal of immunopathology and pharmacology - 1 Jan 2000

Paolini F, Rollo F, Brandi R, Benevolo M, Mariani L, Cercato M C, Vocaturo A, Venuti A

Abstract excerpt

The aim of the present study is to compare the performance of several commercial human papillomavirus (HPV) tests in a cohort of 281 women. The hybrid capture II, the PreTect-HPV-Proofer, the linear array, and DR.HPVTMIVD were utilized to detect and type HPV in parallel with in-house PCR tests fo...

Topics

Adult
Aged
Female
Genotype
Humans
Middle Aged
Papillomaviridae
Papillomavirus Infections
Polymerase Chain Reaction
Prospective Studies
Reagent Kits, Diagnostic
Risk

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Uterine Cervical Neoplasms

Source

Identifiers

PMID: 21496395
DOI: 10.1177/039463201102400115

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-21496395-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High risk human papillomavirus genotyping in clinical samples: evaluation of different commercial tests.PMID 21496395Read ↗

Comparison of four different human papillomavirus genotyping methods in cervical samples: Addressing method-specific advantages and limitationsSemantic proximity Read ↗

Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping.Semantic proximity Read ↗

A direct comparison of four high risk human papilloma virus tests versus the cobas test for detecting cervical intraepithelial neoplasia and cervical cancerSemantic proximity Read ↗

Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.Semantic proximity Read ↗

Chapter 12: Human Papillomavirus TechnologiesSemantic proximity Read ↗

The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening.Semantic proximity Read ↗

Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods.Semantic proximity Read ↗

Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.Semantic proximity Read ↗

Comparison of HPV genotyping assays and Hybrid Capture 2 for detection of high-risk HPV in cervical specimens.Semantic proximity Read ↗

Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.Semantic proximity Read ↗

Molecular detection and genotyping of human papillomavirus.Semantic proximity Read ↗

Evaluation of a Novel Single-Tube Method for Extended Genotyping of Human Papillomavirus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.